Scirrhous hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging: Emphasis on the differentiation of intrahepatic cholangiocarcinoma

Journal of Computer Assisted Tomography

Volumn 37, Issue 6, 2013, Pages 872-881

  Park, Min Jung ^a,b   Kim, Young Kon ^a,b   Park, Hyun Jeong ^b   Hwang, Jiyoung ^c   Lee, Won Jae ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Soonchunhyang University   (South Korea)

Author keywords

cholangiocarcinoma; diffusion weighted imaging; Gd EOB DTPA; MRI; scirrhous hepatocellular carcinoma

Indexed keywords

DIFFUSION; IMAGE ENHANCEMENT; MULTIVARIANT ANALYSIS; TUMORS;

CHOLANGIOCARCINOMA; DIFFUSION WEIGHTED IMAGING; GD-EOB-DTPA; HEPATOBILIARY; HEPATOCELLULAR CARCINOMA; IMAGING FEATURES; MULTI VARIATE ANALYSIS; SCIRRHOUS HEPATOCELLULAR CARCINOMA;

MAGNETIC RESONANCE IMAGING;

GADOXETIC ACID;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE ENHANCEMENT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCIRRHOUS HEPATOCELLULAR CARCINOMA;

EID: 84889010542     PISSN: 03638715     EISSN: 15323145     Source Type: Journal    
DOI: 10.1097/RCT.0b013e31829d44c1     Document Type: Article

References (31)

1. Lee WS, Lee KW, Heo JS, et al. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Surg Today. 2006;36:892-897
2. Shirabe K, Shimada M, Harimoto N, et al. Intrahepatic cholangiocarcinoma: Its mode of spreading and therapeutic modalities. Surgery. 2002;131:S159-S164
3. Choi BI, Han JK, Shin YM, et al. Peripheral cholangiocarcinoma: Comparison of MRI with CT Abdom Imaging. 1995;20:357-360
4. Maetani Y, Itoh K, Watanabe C, et al. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR Am J Roentgenol. 2001;176:1499-1507
5. Fan ZM, Yamashita Y, Harada M, et al. Intrahepatic cholangiocarcinoma: Spin-echo and contrast-enhanced dynamic MR imaging. AJR Am J Roentgenol. 1993;161:313-317
6. Vilgrain V, Van Beers BE, Flejou JF, et al. Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients. J Comput Assist Tomogr. 1997;21:59-65
7. Kurogi M, Nakashima O, Miyaaki H, et al. Clinicopathological study of scirrhous hepatocellular carcinoma. J Gastroenterol Hepatol. 2006;21:1470-1477
8. Seok JY, Na DC, Woo HG, et al. A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition. Hepatology. 2012;55:1776-1786
9. Fujii T, Zen Y, Harada K, et al. Participation of liver cancer stem/progenitor cells in tumorigenesis of scirrhous hepatocellular carcinoma - human and cell culture study. Hum Pathol. 2008;39:1185-1196
10. Okamura N, Yoshida M, Shibuya A, et al. Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: Comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas. Pathol Int. 2005;55:724-731
11. Kim SH, Lim HK, Lee WJ, et al. Scirrhous hepatocellular carcinoma: Comparison with usual hepatocellular carcinoma based on CT-pathologic features and long-term results after curative resection. Eur J Radiol. 2009;69:123-130
12. Goshima S, Kanematsu M, Yamada T, et al. Small scirrhous hepatocellular carcinoma with central scar: MR imaging findings. J Magn Reson Imaging. 2002;16:741-745
13. Gabata T, Matsui O, Kadoya M, et al. Delayed MR imaging of the liver: Correlation of delayed enhancement of hepatic tumors and pathologic appearance. Abdom Imaging. 1998;23:309-313
14. Peterson MS, Murakami T, Baron RL. MRimaging patterns of gadolinium retention within liver neoplasms. Abdom Imaging. 1998;23:592-599
15. Kim YK, Kim CS, Han YM, et al. Detection of hepatocellular carcinoma: Gadoxetic acid-enhanced 3-dimensional magnetic resonance imaging versus multi-detector row computed tomography. J Comput Assist Tomogr. 2009;33:844-850
16. Frericks BB, Loddenkemper C, Huppertz A, et al. Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA. AJR Am J Roentgenol. 2009;193:1053-1060
17. Nasu K, Kuroki Y, Tsukamoto T, et al. Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: Imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade. AJR Am J Roentgenol. 2009;193:438-444
18. Parikh T, Drew SJ, Lee VS, et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: Comparison with standard breath-hold T2-weighted imaging. Radiology. 2008;246: 812-822
19. Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology. 2010;254:47-66
20. Park MJ, Kim YK, Lee MW, et al. Small hepatocellular carcinomas: Improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns. Radiology. 2012;264:761-770
21. Jeon TY, Kim SH, Lee WJ, et al. The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma. Abdom Imaging. 2010;35:337-345
22. Lee JH, Choi MS, Gwak GY, et al. Clinicopathologic characteristics and long-term prognosis of scirrhous hepatocellular carcinoma. Dig Dis Sci. 2012;57:1698-1707
23. El-Serag HB, Engels EA, Landgren O, et al. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans. Hepatology. 2009;49:116-123
24. Lee TY, Lee SS, Jung SW, et al. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: A case-control study. Am J Gastroenterol. 2008;103:1716-1720
25. Yoshikawa J, Matsui O, Kadoya M, et al. Delayed enhancement of fibrotic areas in hepatic masses: CT-pathologic correlation. J Comput Assist Tomogr. 1992;16:206-211
26. Manfredi R, Barbaro B, Masselli G, et al. Magnetic resonance imaging of cholangiocarcinoma. Semin Liver Dis. 2004;24:155-164
27. Soyer P, Bluemke DA, Reichle R, et al. Imaging of intrahepatic cholangiocarcinoma: 1. Peripheral cholangiocarcinoma. AJR Am J Roentgenol. 1995;165:1427-1431
28. Matsuura S, Aishima S, Taguchi K, et al. "Scirrhous" type hepatocellular carcinomas: A special reference to expression of cytokeratin 7 and hepatocyte paraffin 1. Histopathology. 2005;47:382-390
29. Kim SA, Lee JM, Lee KB, et al. Intrahepatic mass-forming cholangiocarcinomas: Enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern - correlation with clinicopathologic findings. Radiology. 2011;260:148-157
30. Kim SJ, Lee JM, Han JK, et al. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver. AJR Am J Roentgenol. 2007;189:1428-1434
31. Kim YK, Han YM, Kim CS. Comparison of diffuse hepatocellular carcinoma and intrahepatic cholangiocarcinoma using sequentially acquired gadolinium-enhanced and Resovist-enhanced MRI. Eur J Radiol. 2009;70:94-100